Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study

被引：0
作者：
Laura Miotke
Christopher Nevala-Plagemann
Jian Ying
Vaia Florou
Benjamin Haaland
Ignacio Garrido-Laguna
机构：
[1] Huntsman Cancer Institute,Division of Medical Oncology
[2] University of Utah School of Medicine,Department of Internal Medicine
[3] Department of Population Health Sciences,undefined
来源：
BMC Cancer | / 22卷
关键词：
Real-world outcomes; Overall survival; Pancreatic ductal adenocarcinoma; Recurrent; De Novo;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study
    Miotke, Laura
    Nevala-Plagemann, Christopher
    Ying, Jian
    Florou, Vaia
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    BMC CANCER, 2022, 22 (01)
  • [2] Real-world clinical outcome of unresectable locally advanced & de-novo metastatic pancreatic ductal adenocarcinoma: a multicentre retrospective study
    Aseafan, Mohamed
    Alfakeeh, Ali H.
    Tashkandi, Emad
    Mahrous, Mervat
    Alghamdi, Mohammed
    Alshamsan, Bader
    Al-Hajeili, Marwan
    Bakhsh, Safwan
    Alshammari, Kanan
    Almugbel, Fahad A.
    Alfagih, Abdulhameed H.
    Allehebi, Ahmed
    Montaser, Mohamed
    Elsafty, Mohamed Hamdy
    Elnaghi, Khaled Abd Elaziz
    Issa, Ibrahim
    Bakshi, Eesa
    Alsubaie, Sadeem
    Almutairi, Bandar
    Mokhtar, Hoda
    Aboelatta, Mohamed
    Bukhari, Nedal
    Alzahrani, Ali M.
    Elhassan, Tusneem
    Alqahtani, Ali
    Bazarbashi, Shouki
    BMC CANCER, 2025, 25 (01)
  • [3] Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinoma
    Kim, George P.
    Surinach, Andy
    Corvino, Frank A.
    Cockrum, Paul
    Belanger, Bruce
    Abushahin, Laith
    FUTURE ONCOLOGY, 2021, 17 (06) : 675 - 688
  • [4] Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: a systematic review
    Cockrum, Paul
    Dennen, Syvart
    Brown, Audrey
    Briggs, Jonathon
    Paluri, Ravi
    FUTURE ONCOLOGY, 2025, 21 (02) : 241 - 260
  • [5] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    King, Gentry
    Ittershagen, Stacie
    He, Luyang
    Shen, Ying
    Li, Frank
    Villacorta, Reginald
    ADVANCES IN THERAPY, 2022, 39 (12) : 5433 - 5452
  • [6] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    Gentry King
    Stacie Ittershagen
    Luyang He
    Ying Shen
    Frank Li
    Reginald Villacorta
    Advances in Therapy, 2022, 39 : 5433 - 5452
  • [7] Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung Cancer
    Moore, Sara
    Leung, Bonnie
    Wu, Jonn
    Ho, Cheryl
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 292 - 297
  • [8] Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
    Kang, Sora
    Yoo, Changhoon
    Lee, So Heun
    Oh, Dongwook
    Song, Tae Jun
    Lee, Sang Soo
    Jeong, Jae Ho
    Park, Do Hyun
    Seo, Dong Wan
    Park, Jin-hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Kwak, Bong Jun
    Hong, Sarang
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Kim, Kyu-pyo
    Kim, Song Cheol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [9] De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry
    Tripathy, Debu
    Brufsky, Adam
    Cobleigh, Melody
    Jahanzeb, Mohammad
    Kaufman, Peter A.
    Mason, Ginny
    O'Shaughnessy, Joyce
    Rugo, Hope S.
    Swain, Sandra M.
    Yardley, Denise A.
    Chu, Laura
    Li, Haocheng
    Antao, Vincent
    Hurvitz, Sara A.
    ONCOLOGIST, 2020, 25 (02) : E214 - E222
  • [10] Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma
    Alessandro Fogliati
    Andrea Zironda
    Guido Fiorentini
    Stella Adjei
    Abdelrahman Amro
    Patrick P. Starlinger
    Travis E. Grotz
    Susanne G. Warner
    Rory L. Smoot
    Cornelius A. Thiels
    Michael L. Kendrick
    Sean P. Cleary
    Mark J. Truty
    Annals of Surgical Oncology, 2024, 31 : 2632 - 2639
12345